Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil
Reactive oxygen species, such as hypochlorite induce oxidative stress, which impairs nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signalling and leads to vascular dysfunction. It has been proposed, that elevated cGMP-levels may contribute to an effective cytoprotection against oxidative s...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
23 April 2013
|
| In: |
European journal of pharmacology
Year: 2013, Jahrgang: 710, Heft: 1/3, Pages: 110-119 |
| ISSN: | 1879-0712 |
| DOI: | 10.1016/j.ejphar.2013.04.012 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ejphar.2013.04.012 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0014299913003051?via%3Dihub 
|
| Verfasserangaben: | Tamás Radovits, Rawa Arif, Timo Bömicke, Sevil Korkmaz, Enikő Barnucz, Matthias Karck, Béla Merkely, Gábor Szabó |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1782003231 | ||
| 003 | DE-627 | ||
| 005 | 20230426163127.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211213s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejphar.2013.04.012 |2 doi | |
| 035 | |a (DE-627)1782003231 | ||
| 035 | |a (DE-599)KXP1782003231 | ||
| 035 | |a (OCoLC)1341436225 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Radovits, Tamás |e VerfasserIn |0 (DE-588)1081943203 |0 (DE-627)846898101 |0 (DE-576)454965869 |4 aut | |
| 245 | 1 | 0 | |a Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil |c Tamás Radovits, Rawa Arif, Timo Bömicke, Sevil Korkmaz, Enikő Barnucz, Matthias Karck, Béla Merkely, Gábor Szabó |
| 264 | 1 | |c 23 April 2013 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.12.2021 | ||
| 520 | |a Reactive oxygen species, such as hypochlorite induce oxidative stress, which impairs nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signalling and leads to vascular dysfunction. It has been proposed, that elevated cGMP-levels may contribute to an effective cytoprotection against oxidative stress. We investigated the effects of vardenafil, a selective inhibitor of the cGMP-degrading phosphodiesterase-5 enzyme on vascular dysfunction induced by hypochlorite. In organ bath experiments for isometric tension, we investigated the endothelium-dependent and endothelium-independent vasorelaxation of isolated rat aortic rings using cumulative concentrations of acetylcholine and sodium nitroprusside (SNP). Vascular dysfunction was induced by exposing rings to hypochlorite (100-400 µM). In the treatment groups, rats were pretreated with vardenafil (30 and 300 µg/kg i.v.). Immunohistochemical analysis was performed for the oxidative stress markers nitrotyrosine, poly(ADP-ribose) and for apoptosis inducing factor (AIF). Exposure to hypochlorite resulted in a marked impairment of acetylcholine-induced endothelium-dependent vasorelaxation of aortic rings. Pretreatment with vardenafil led to improved endothelial function as reflected by the higher maximal vasorelaxation (Rmax) to acetylcholine. Regarding endothelium-independent vasorelaxation, hypochlorite exposure led to a left-shift of SNP concentration-response curves in the vardenafil groups without any alterations of the Rmax. In the hypochlorite groups immunohistochemical analysis showed enhanced poly(ADP-ribose)-formation and nuclear translocation of AIF, which were prevented by vardenafil-pretreatment. Our results support the view that cytoprotective effects of PDE-5-inhibitors on the endothelium may underlie the improved endothelial function, however, a slight sensitisation of vascular smooth muscle to NO was also confirmed. PDE-5-inhibition may represent a potential therapy approach for treating vascular dysfunction induced by oxidative stress. | ||
| 650 | 4 | |a Acetylcholine | |
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Aorta, Thoracic | |
| 650 | 4 | |a Endothelium, Vascular | |
| 650 | 4 | |a Hypochlorous Acid | |
| 650 | 4 | |a Imidazoles | |
| 650 | 4 | |a In Vitro Techniques | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Nitroprusside | |
| 650 | 4 | |a Oxidants | |
| 650 | 4 | |a Oxidative Stress | |
| 650 | 4 | |a Phenylephrine | |
| 650 | 4 | |a Phosphodiesterase 5 Inhibitors | |
| 650 | 4 | |a Piperazines | |
| 650 | 4 | |a Rats | |
| 650 | 4 | |a Rats, Sprague-Dawley | |
| 650 | 4 | |a Sulfones | |
| 650 | 4 | |a Triazines | |
| 650 | 4 | |a Vardenafil Dihydrochloride | |
| 650 | 4 | |a Vasoconstrictor Agents | |
| 650 | 4 | |a Vasodilation | |
| 650 | 4 | |a Vasodilator Agents | |
| 700 | 1 | |a Arif, Rawa |d 1984- |e VerfasserIn |0 (DE-588)1023582775 |0 (DE-627)718414071 |0 (DE-576)367034530 |4 aut | |
| 700 | 1 | |a Bömicke, Timo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Korkmaz-İçöz, Sevil |e VerfasserIn |0 (DE-588)1062748697 |0 (DE-627)806830336 |0 (DE-576)420147845 |4 aut | |
| 700 | 1 | |a Barnucz, Enikő |e VerfasserIn |4 aut | |
| 700 | 1 | |a Karck, Matthias |d 1961- |e VerfasserIn |0 (DE-588)130833525 |0 (DE-627)505909340 |0 (DE-576)298366169 |4 aut | |
| 700 | 1 | |a Merkely, Béla |e VerfasserIn |4 aut | |
| 700 | 1 | |a Szabó, Gábor |d 1969- |e VerfasserIn |0 (DE-588)1022955152 |0 (DE-627)717338681 |0 (DE-576)366215485 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of pharmacology |d New York, NY [u.a.] : Elsevier, 1967 |g 710(2013), 1/3 vom: 15. Juni, Seite 110-119 |h Online-Ressource |w (DE-627)300897340 |w (DE-600)1483526-5 |w (DE-576)081952627 |x 1879-0712 |7 nnas |a Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil |
| 773 | 1 | 8 | |g volume:710 |g year:2013 |g number:1/3 |g day:15 |g month:06 |g pages:110-119 |g extent:10 |a Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejphar.2013.04.012 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0014299913003051?via%3Dihub |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211213 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1022955152 |a Szabó, Gábor |m 1022955152:Szabó, Gábor |d 910000 |d 910200 |d 50000 |e 910000PS1022955152 |e 910200PS1022955152 |e 50000PS1022955152 |k 0/910000/ |k 1/910000/910200/ |k 0/50000/ |p 8 |y j | ||
| 998 | |g 130833525 |a Karck, Matthias |m 130833525:Karck, Matthias |d 910000 |d 910200 |e 910000PK130833525 |e 910200PK130833525 |k 0/910000/ |k 1/910000/910200/ |p 6 | ||
| 998 | |g 1062748697 |a Korkmaz-İçöz, Sevil |m 1062748697:Korkmaz-İçöz, Sevil |d 910000 |d 910200 |e 910000PK1062748697 |e 910200PK1062748697 |k 0/910000/ |k 1/910000/910200/ |p 4 | ||
| 998 | |g 1023582775 |a Arif, Rawa |m 1023582775:Arif, Rawa |d 910000 |d 910200 |e 910000PA1023582775 |e 910200PA1023582775 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 999 | |a KXP-PPN1782003231 |e 401947365X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"10 S."}],"id":{"doi":["10.1016/j.ejphar.2013.04.012"],"eki":["1782003231"]},"title":[{"title":"Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil","title_sort":"Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil"}],"person":[{"family":"Radovits","role":"aut","display":"Radovits, Tamás","given":"Tamás"},{"display":"Arif, Rawa","given":"Rawa","role":"aut","family":"Arif"},{"family":"Bömicke","display":"Bömicke, Timo","given":"Timo","role":"aut"},{"family":"Korkmaz-İçöz","role":"aut","display":"Korkmaz-İçöz, Sevil","given":"Sevil"},{"family":"Barnucz","role":"aut","given":"Enikő","display":"Barnucz, Enikő"},{"role":"aut","display":"Karck, Matthias","given":"Matthias","family":"Karck"},{"display":"Merkely, Béla","given":"Béla","role":"aut","family":"Merkely"},{"family":"Szabó","role":"aut","display":"Szabó, Gábor","given":"Gábor"}],"name":{"displayForm":["Tamás Radovits, Rawa Arif, Timo Bömicke, Sevil Korkmaz, Enikő Barnucz, Matthias Karck, Béla Merkely, Gábor Szabó"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"recId":"300897340","origin":[{"publisher":"Elsevier","dateIssuedDisp":"1967-","dateIssuedKey":"1967","publisherPlace":"New York, NY [u.a.]"}],"pubHistory":["1.1967 -"],"id":{"eki":["300897340"],"zdb":["1483526-5"],"issn":["1879-0712"]},"language":["eng"],"titleAlt":[{"title":"EJP"}],"part":{"issue":"1/3","extent":"10","volume":"710","text":"710(2013), 1/3 vom: 15. Juni, Seite 110-119","pages":"110-119","year":"2013"},"title":[{"title":"European journal of pharmacology","subtitle":"EJP","title_sort":"European journal of pharmacology"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafilEuropean journal of pharmacology","type":{"bibl":"periodical","media":"Online-Ressource"}}],"recId":"1782003231","note":["Gesehen am 13.12.2021"],"origin":[{"dateIssuedDisp":"23 April 2013","dateIssuedKey":"2013"}]} | ||
| SRT | |a RADOVITSTAVASCULARDY2320 | ||